Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events afterorthotopic liver transplantation

Lisa G. Umphrey, R. Todd Hurst, Mackram F. Eleid, Kwan S. Lee, Christina S. Reuss, Joseph G. Hentz, Hugo E. Vargas, Christopher P. Appleton

Research output: Contribution to journalArticlepeer-review

76 Scopus citations


Cardiovascular (CV) complications are the leading cause of -graft-related death in orthotopic liver transplant (OLT) patients. Pretransplant cardiac evaluation using dobutamine stress echocardiography (DSE) is commonly utilized for risk stratification of OLT candidates. To determine if clinical and echocardiographic variables identify patients with increased CV risk, we performed a retrospective chart review of all 284 patients that underwent OLT at our institution between June 1999 and August 2005. Of these patients, 157 had a DSE prior to their OLT. Serious adverse CV events occurring during surgery and up to 4 months post-transplantation were defined as cardiac-related death, myocardial infarction (MI), new heart failure, or asystole or unstable ventricular arrhythmia requiring acute treatment. Sixteen of 157 patients (10%) had an adverse CV event with 2 deaths. These included ventricular tachycardia (n = 8), asystole (n = 2), MI (n = 5), and new heart failure (n = 1). Nine of the 16 CV events occurred at the time of surgery (including both deaths), 5 occurred postoperatively, and 3 occurred after hospital discharge. Variables that correlated with increased CV events were inability during DSE to achieve >82% of the maximum predicted heart rate (22% versus 6%, P = 0.01), a peak rate pressure product during DSE of <16,333 (17% versus 5%, P = 0.02), and a Model for End-Stage Liver Disease (MELD) score of >24 at the time of OLT. A multivariate model calculated from the DSE maximum achieved heart rate (MAHR) and MELD score (result = 3.78 + 0.07 MELD - 0.05 MAHR) identified a 47% risk for a value > 0 versus a 6% risk for a value < 0 (P < 0.001). In conclusion, the maximum heart rate achieved during DSE together with the MELD score may be a predictor of adverse CV events up to 4 months post-OLT. A large prospective study is needed to more decisively support this conclusion.

Original languageEnglish (US)
Pages (from-to)886-892
Number of pages7
JournalLiver Transplantation
Issue number6
StatePublished - Jun 2008

ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation


Dive into the research topics of 'Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events afterorthotopic liver transplantation'. Together they form a unique fingerprint.

Cite this